Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Yael C, Cohen"'
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/b0ccedec52f64115a6b5af52170681c8
Publikováno v:
eJHaem, Vol 3, Iss 2, Pp 471-474 (2022)
Abstract Patients with lymphoproliferative diseases are at high risk for SARS‐CoV‐2‐related complications and mortality. The role of casirivimab and imdevimab (REGEN‐COV), a neutralizing antibody cocktail, to treat immunocompromised hemato‐
Externí odkaz:
https://doaj.org/article/6c270e70ac324e938a13feae8c0f7fcd
Autor:
Adam D. Cohen, María-Victoria Mateos, Yael C. Cohen, Paula Rodriguez-Otero, Bruno Paiva, Niels W. C. J. van de Donk, Thomas Martin, Attaya Suvannasankha, Kevin C. De Braganca, Christina Corsale, Jordan M. Schecter, Helen Varsos, William Deraedt, Liwei Wang, Martin Vogel, Tito Roccia, Xiaoying Xu, Pankaj Mistry, Enrique Zudaire, Muhammad Akram, Tonia Nesheiwat, Lida Pacaud, Irit Avivi, Jesus San-Miguel
Publikováno v:
Blood, 141(3), 219-230. American Society of Hematology
Cohen, A D, Mateos, M-V, Cohen, Y C, Rodriguez-Otero, P, Paiva, B, van de Donk, N W C J, Martin, T, Suvannasankha, A, de Braganca, K C, Corsale, C, Schecter, J M, Varsos, H, Deraedt, W, Wang, L, Vogel, M, Roccia, T, Xu, X, Mistry, P, Zudaire, E, Akram, M, Nesheiwat, T, Pacaud, L, Avivi, I & San-Miguel, J 2023, ' Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents ', Blood, vol. 141, no. 3, pp. 219-230 . https://doi.org/10.1182/blood.2022015526
Cohen, A D, Mateos, M-V, Cohen, Y C, Rodriguez-Otero, P, Paiva, B, van de Donk, N W C J, Martin, T, Suvannasankha, A, de Braganca, K C, Corsale, C, Schecter, J M, Varsos, H, Deraedt, W, Wang, L, Vogel, M, Roccia, T, Xu, X, Mistry, P, Zudaire, E, Akram, M, Nesheiwat, T, Pacaud, L, Avivi, I & San-Miguel, J 2023, ' Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents ', Blood, vol. 141, no. 3, pp. 219-230 . https://doi.org/10.1182/blood.2022015526
B-cell maturation antigen (BCMA)–targeting therapies, including bispecific antibodies (BsAbs) and antibody-drug conjugates (ADCs), are promising treatments for multiple myeloma (MM), but disease may progress after their use. CARTITUDE-2 is a phase
Autor:
Tamir, Shragai, Hila, Magen, Noa, Lavi, Moshe, Gatt, Svetlana, Trestman, Miri, Zektser, Chezi, Ganzel, Osnat, Jarchowsky, Tamar, Berger, Tamar, Tadmor, Merav, Leiba, Katrin, Hertzog-Tzarfaty, Netanel, Horowitz, Michael, Shapira, David, Varssano, Yoav, Berger, Shahar, Frenkel, Mark, Krauthammer, Irit, Avivi, Efrat, Luttwak, Yael C, Cohen
Publikováno v:
British Journal of Haematology. 200:45-53
Belantamab mafodotin, an immuno-conjugate targeting B-cell maturation antigen, showed single-agent activity in phase 1 and 2 studies, and was recently approved for heavily pretreated relapsed/refractory multiple myeloma (RRMM) patients. Real-world da
Autor:
Marc S. Raab, Yael C. Cohen, Fredrik Schjesvold, Kimberly Aardalen, Adwait Oka, Andrew Spencer, Martin Wermke, Anita D. Souza, Jonathan L. Kaufman, Anna Maria Cafro, Enrique M. Ocio, Noriko Doki, Kristin Henson, Gina Trabucco, Ana Carrion, Florent C. Bender, Pierre-Eric Juif, Adonai Fessehatsion, Liqiong Fan, Jeffrey P. Stonehouse, John W. Blankenship, Brian Granda, Serena De Vita, Haihui Lu
Publikováno v:
Leukemia.
Autor:
Moshe E. Gatt, Polina Stepensky, Cyrille J. Cohen, Irit Avivi, Yael C. Cohen, Adir Shaulov, Eyal Lebel, Marjorie Pick, Tatyana Dubnikov Sharon, Miri Assayag, Eran Zimran, Batia Avni, Sigal Grisariu, Nathalie Asherie, Shlomit Kfir-Erenfeld
Purpose:AL amyloidosis (AL) treatments are generally based on those employed for multiple myeloma. Anti–B-cell maturation antigen (BCMA) chimeric antigen receptor T (CART)-cell therapy, already approved for multiple myeloma, might be too toxic for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4931dc3b0ab164faee6fee17bf5a452f
https://doi.org/10.1158/1078-0432.c.6532965.v1
https://doi.org/10.1158/1078-0432.c.6532965.v1
Autor:
Moshe E. Gatt, Polina Stepensky, Cyrille J. Cohen, Irit Avivi, Yael C. Cohen, Adir Shaulov, Eyal Lebel, Marjorie Pick, Tatyana Dubnikov Sharon, Miri Assayag, Eran Zimran, Batia Avni, Sigal Grisariu, Nathalie Asherie, Shlomit Kfir-Erenfeld
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5fe8b22f971cc97e695a3062476981
https://doi.org/10.1158/1078-0432.22489473.v1
https://doi.org/10.1158/1078-0432.22489473.v1
Autor:
Moshe E. Gatt, Polina Stepensky, Cyrille J. Cohen, Irit Avivi, Yael C. Cohen, Adir Shaulov, Eyal Lebel, Marjorie Pick, Tatyana Dubnikov Sharon, Miri Assayag, Eran Zimran, Batia Avni, Sigal Grisariu, Nathalie Asherie, Shlomit Kfir-Erenfeld
Release testing criteria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bc53eb2f9646bab964efac144ab119e
https://doi.org/10.1158/1078-0432.22489467.v1
https://doi.org/10.1158/1078-0432.22489467.v1
Autor:
Moshe E. Gatt, Polina Stepensky, Cyrille J. Cohen, Irit Avivi, Yael C. Cohen, Adir Shaulov, Eyal Lebel, Marjorie Pick, Tatyana Dubnikov Sharon, Miri Assayag, Eran Zimran, Batia Avni, Sigal Grisariu, Nathalie Asherie, Shlomit Kfir-Erenfeld
Supplementary Figures S1-S7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::052ebbb526935579ed944104023bd720
https://doi.org/10.1158/1078-0432.22489470
https://doi.org/10.1158/1078-0432.22489470
Autor:
Adam D. Cohen, María-Victoria Mateos, Yael C. Cohen, Paula Rodriguez Otero, Bruno Paiva, Niels W.C.J. Van De Donk, Thomas Martin, Attaya Suvannasankha, Christina Corsale, Jordan M. Schecter, Kevin C. De Braganca, Carolyn C. Jackson, Helen Varsos, William Deraedt, Tito Roccia, Pankaj Mistry, Xiaoying Xu, Katherine Li, Enrique Zudaire, Muhammad Akram, Lida Pacaud, Irit Avivi, Jesús San-Miguel
Publikováno v:
Blood. 140:4646-4648